A Real World Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)
A Randomized, Open-label, Parallel Group Real World Pragmatic Trial to Assess the Clinical and Health Outcomes of Toujeo Compared to Commercially Available Basal Insulins for Initiation of Therapy in Insulin-naive Patients With Uncontrolled Type 2 Diabetes Mellitus
Sponsor: Sanofi
Listed as NCT02451137, this PHASE4 trial focuses on Diabetes Mellitus, Type 2 and remains completed. Sponsored by Sanofi, it has been updated 18 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
18 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Oct 2019 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 13 earlier versions
-
Sep 2019 — Oct 2019 [monthly]
Completed PHASE4
-
Jun 2019 — Sep 2019 [monthly]
Completed PHASE4
-
Sep 2018 — Jun 2019 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting PHASE4
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
-
Nov 2017 — May 2018 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Oct 2017 — Nov 2017 [monthly]
Recruiting PHASE4
-
Jun 2017 — Oct 2017 [monthly]
Recruiting PHASE4
-
May 2017 — Jun 2017 [monthly]
Recruiting PHASE4
-
Apr 2017 — May 2017 [monthly]
Recruiting PHASE4
-
Mar 2017 — Apr 2017 [monthly]
Recruiting PHASE4
-
Feb 2017 — Mar 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sanofi
For direct contact, visit the study record on ClinicalTrials.gov .